Matches in Nanopublications for { ?s ?p "[Altogether, these data provide evidence that the repression of syndecan-2 by Wnt/?-catenin/TCF signaling contributes to the resistance of osteosarcoma cells to doxorubicin and suggest that TCF inhibition may represent a novel therapeutic strategy in osteosarcoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP306577.RATqnPseKCcz17ZBNG-gB6CKNHSnH6GfeotxXK5JilY7M130_assertion description "[Altogether, these data provide evidence that the repression of syndecan-2 by Wnt/?-catenin/TCF signaling contributes to the resistance of osteosarcoma cells to doxorubicin and suggest that TCF inhibition may represent a novel therapeutic strategy in osteosarcoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP306577.RATqnPseKCcz17ZBNG-gB6CKNHSnH6GfeotxXK5JilY7M130_provenance.
- NP461488.RAV9sBbBM9qtTHu_buot8lUuEjwHvxW3qBuc7vU2ja0IA130_assertion description "[Altogether, these data provide evidence that the repression of syndecan-2 by Wnt/?-catenin/TCF signaling contributes to the resistance of osteosarcoma cells to doxorubicin and suggest that TCF inhibition may represent a novel therapeutic strategy in osteosarcoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP461488.RAV9sBbBM9qtTHu_buot8lUuEjwHvxW3qBuc7vU2ja0IA130_provenance.
- NP689164.RA0R8MYrClDRvSqozKK9x2njH7Qg_GHf7049qK1RPar2w130_assertion description "[Altogether, these data provide evidence that the repression of syndecan-2 by Wnt/?-catenin/TCF signaling contributes to the resistance of osteosarcoma cells to doxorubicin and suggest that TCF inhibition may represent a novel therapeutic strategy in osteosarcoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP689164.RA0R8MYrClDRvSqozKK9x2njH7Qg_GHf7049qK1RPar2w130_provenance.
- NP461407.RAq0oK2scHqPZb_j0TQBKv7Qm_vzCeok6DDxKGEzbp08s130_assertion description "[Altogether, these data provide evidence that the repression of syndecan-2 by Wnt/?-catenin/TCF signaling contributes to the resistance of osteosarcoma cells to doxorubicin and suggest that TCF inhibition may represent a novel therapeutic strategy in osteosarcoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP461407.RAq0oK2scHqPZb_j0TQBKv7Qm_vzCeok6DDxKGEzbp08s130_provenance.
- NP978943.RABi8fZ0RgGvjWQDK5G7rzoFkmhLuTFcm8EiSA8F2SJas130_assertion description "[Altogether, these data provide evidence that the repression of syndecan-2 by Wnt/?-catenin/TCF signaling contributes to the resistance of osteosarcoma cells to doxorubicin and suggest that TCF inhibition may represent a novel therapeutic strategy in osteosarcoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978943.RABi8fZ0RgGvjWQDK5G7rzoFkmhLuTFcm8EiSA8F2SJas130_provenance.
- NP978942.RA9HGaDPEbjS6l4q0HXfqyvtSLxJI0Q2mx8fgF8E-TqDM130_assertion description "[Altogether, these data provide evidence that the repression of syndecan-2 by Wnt/?-catenin/TCF signaling contributes to the resistance of osteosarcoma cells to doxorubicin and suggest that TCF inhibition may represent a novel therapeutic strategy in osteosarcoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978942.RA9HGaDPEbjS6l4q0HXfqyvtSLxJI0Q2mx8fgF8E-TqDM130_provenance.